Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins

Raquel Rabionet, Paolo Gasparini, Xavier P. Estivill

Research output: Contribution to journalReview article

171 Citations (Scopus)

Abstract

Deafness is a complex disorder that involves a high number of genes and environmental factors. There has been enormous progress in non-syndromic deafness research during the last five years, with the identification of over 50 loci and 15 genes. Among these, three genes, GSB2, GSB3, and GSB6, encode for connexin proteins (Connexin26, Connexin31, and Connexin30, respectively). Another connexin (Connexin32, encoded by GJB1) is involved in X-linked peripheral neuropathy and hearing impairment. Mutations in these genes cause autosomal recessive (GJB2 and GJB3), autosomal dominant (GJB2, GJB3, and GJB6) or X-linked (GJB1) hearing impairment, both syndromic (GJB2, keratoderma; GSB3 erythrokeratodermia variabilis; and GSB1, peripheral neuropathy), and non-syndromic (GJB2, GSB3, and GSB6). Among these genes, mutations in GSB2 account for about 50% of all congenital cases of hearing impairment. Three mutations in GSB2 (35delG, 167delT, and 235delC) are particularly common in specific populations (Caucasoid, Jewish Ashkenazi, and Oriental, respectively), leading to carrier frequencies between one in 30 and one in 75. Over 50 mutations have been identified in the GSB2 gene, of which some missense changes (M34T, W44C, G59A, D66H, and R75W) have a negative dominant action in hearing impairment, with partial to full penetrance. Functional studies for some missense mutations in connexins 26, 30, and 32 have indicated abnormal gap junction conductivity. Expression patterns in mouse and rat cochlea indicate that Connexin26 and Connexin30 are expressed in the supportive cells of the cochlea, suggesting a potential role in endolymph potassium recycling. The high prevalence of mutations in GSB2 in some populations provides the tools for molecular diagnosis, carrier detection, and prenatal diagnosis of congenital hearing impairment. (C) 2000 Wiley-Liss, Inc.

Original languageEnglish
Pages (from-to)190-202
Number of pages13
JournalHuman Mutation
Volume16
Issue number3
DOIs
Publication statusPublished - 2000
Externally publishedYes

Fingerprint

Connexins
Gap Junctions
Hearing Loss
Molecular Biology
Mutation
Genes
Cochlea
Deafness
Peripheral Nervous System Diseases
Erythrokeratodermia Variabilis
Endolymph
Penetrance
Recycling
Missense Mutation
Prenatal Diagnosis
Population
Potassium
Research
Proteins

Keywords

  • CMTX1
  • Connexin, beta
  • Deafness
  • DF NA2
  • DFNA3
  • DFNB1
  • Erythrokeratodermia
  • Gap junction protein
  • GJB1
  • GJB2
  • GJB3
  • GJB6
  • Hearing impairment, non-syndromic

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins. / Rabionet, Raquel; Gasparini, Paolo; Estivill, Xavier P.

In: Human Mutation, Vol. 16, No. 3, 2000, p. 190-202.

Research output: Contribution to journalReview article

@article{8ce20491516f426fa68c78688f127a87,
title = "Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins",
abstract = "Deafness is a complex disorder that involves a high number of genes and environmental factors. There has been enormous progress in non-syndromic deafness research during the last five years, with the identification of over 50 loci and 15 genes. Among these, three genes, GSB2, GSB3, and GSB6, encode for connexin proteins (Connexin26, Connexin31, and Connexin30, respectively). Another connexin (Connexin32, encoded by GJB1) is involved in X-linked peripheral neuropathy and hearing impairment. Mutations in these genes cause autosomal recessive (GJB2 and GJB3), autosomal dominant (GJB2, GJB3, and GJB6) or X-linked (GJB1) hearing impairment, both syndromic (GJB2, keratoderma; GSB3 erythrokeratodermia variabilis; and GSB1, peripheral neuropathy), and non-syndromic (GJB2, GSB3, and GSB6). Among these genes, mutations in GSB2 account for about 50{\%} of all congenital cases of hearing impairment. Three mutations in GSB2 (35delG, 167delT, and 235delC) are particularly common in specific populations (Caucasoid, Jewish Ashkenazi, and Oriental, respectively), leading to carrier frequencies between one in 30 and one in 75. Over 50 mutations have been identified in the GSB2 gene, of which some missense changes (M34T, W44C, G59A, D66H, and R75W) have a negative dominant action in hearing impairment, with partial to full penetrance. Functional studies for some missense mutations in connexins 26, 30, and 32 have indicated abnormal gap junction conductivity. Expression patterns in mouse and rat cochlea indicate that Connexin26 and Connexin30 are expressed in the supportive cells of the cochlea, suggesting a potential role in endolymph potassium recycling. The high prevalence of mutations in GSB2 in some populations provides the tools for molecular diagnosis, carrier detection, and prenatal diagnosis of congenital hearing impairment. (C) 2000 Wiley-Liss, Inc.",
keywords = "CMTX1, Connexin, beta, Deafness, DF NA2, DFNA3, DFNB1, Erythrokeratodermia, Gap junction protein, GJB1, GJB2, GJB3, GJB6, Hearing impairment, non-syndromic",
author = "Raquel Rabionet and Paolo Gasparini and Estivill, {Xavier P.}",
year = "2000",
doi = "10.1002/1098-1004(200009)16:3<190::AID-HUMU2>3.0.CO;2-I",
language = "English",
volume = "16",
pages = "190--202",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Molecular genetics of hearing impairment due to mutations in gap junction genes encoding beta connexins

AU - Rabionet, Raquel

AU - Gasparini, Paolo

AU - Estivill, Xavier P.

PY - 2000

Y1 - 2000

N2 - Deafness is a complex disorder that involves a high number of genes and environmental factors. There has been enormous progress in non-syndromic deafness research during the last five years, with the identification of over 50 loci and 15 genes. Among these, three genes, GSB2, GSB3, and GSB6, encode for connexin proteins (Connexin26, Connexin31, and Connexin30, respectively). Another connexin (Connexin32, encoded by GJB1) is involved in X-linked peripheral neuropathy and hearing impairment. Mutations in these genes cause autosomal recessive (GJB2 and GJB3), autosomal dominant (GJB2, GJB3, and GJB6) or X-linked (GJB1) hearing impairment, both syndromic (GJB2, keratoderma; GSB3 erythrokeratodermia variabilis; and GSB1, peripheral neuropathy), and non-syndromic (GJB2, GSB3, and GSB6). Among these genes, mutations in GSB2 account for about 50% of all congenital cases of hearing impairment. Three mutations in GSB2 (35delG, 167delT, and 235delC) are particularly common in specific populations (Caucasoid, Jewish Ashkenazi, and Oriental, respectively), leading to carrier frequencies between one in 30 and one in 75. Over 50 mutations have been identified in the GSB2 gene, of which some missense changes (M34T, W44C, G59A, D66H, and R75W) have a negative dominant action in hearing impairment, with partial to full penetrance. Functional studies for some missense mutations in connexins 26, 30, and 32 have indicated abnormal gap junction conductivity. Expression patterns in mouse and rat cochlea indicate that Connexin26 and Connexin30 are expressed in the supportive cells of the cochlea, suggesting a potential role in endolymph potassium recycling. The high prevalence of mutations in GSB2 in some populations provides the tools for molecular diagnosis, carrier detection, and prenatal diagnosis of congenital hearing impairment. (C) 2000 Wiley-Liss, Inc.

AB - Deafness is a complex disorder that involves a high number of genes and environmental factors. There has been enormous progress in non-syndromic deafness research during the last five years, with the identification of over 50 loci and 15 genes. Among these, three genes, GSB2, GSB3, and GSB6, encode for connexin proteins (Connexin26, Connexin31, and Connexin30, respectively). Another connexin (Connexin32, encoded by GJB1) is involved in X-linked peripheral neuropathy and hearing impairment. Mutations in these genes cause autosomal recessive (GJB2 and GJB3), autosomal dominant (GJB2, GJB3, and GJB6) or X-linked (GJB1) hearing impairment, both syndromic (GJB2, keratoderma; GSB3 erythrokeratodermia variabilis; and GSB1, peripheral neuropathy), and non-syndromic (GJB2, GSB3, and GSB6). Among these genes, mutations in GSB2 account for about 50% of all congenital cases of hearing impairment. Three mutations in GSB2 (35delG, 167delT, and 235delC) are particularly common in specific populations (Caucasoid, Jewish Ashkenazi, and Oriental, respectively), leading to carrier frequencies between one in 30 and one in 75. Over 50 mutations have been identified in the GSB2 gene, of which some missense changes (M34T, W44C, G59A, D66H, and R75W) have a negative dominant action in hearing impairment, with partial to full penetrance. Functional studies for some missense mutations in connexins 26, 30, and 32 have indicated abnormal gap junction conductivity. Expression patterns in mouse and rat cochlea indicate that Connexin26 and Connexin30 are expressed in the supportive cells of the cochlea, suggesting a potential role in endolymph potassium recycling. The high prevalence of mutations in GSB2 in some populations provides the tools for molecular diagnosis, carrier detection, and prenatal diagnosis of congenital hearing impairment. (C) 2000 Wiley-Liss, Inc.

KW - CMTX1

KW - Connexin, beta

KW - Deafness

KW - DF NA2

KW - DFNA3

KW - DFNB1

KW - Erythrokeratodermia

KW - Gap junction protein

KW - GJB1

KW - GJB2

KW - GJB3

KW - GJB6

KW - Hearing impairment, non-syndromic

UR - http://www.scopus.com/inward/record.url?scp=0033850250&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033850250&partnerID=8YFLogxK

U2 - 10.1002/1098-1004(200009)16:3<190::AID-HUMU2>3.0.CO;2-I

DO - 10.1002/1098-1004(200009)16:3<190::AID-HUMU2>3.0.CO;2-I

M3 - Review article

VL - 16

SP - 190

EP - 202

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 3

ER -